PMS Registry
Company Name
Boehringer Ingelheim Taiwan Limited
Protocol Number
Title of Study
GLORIA-AF: Global Registry, on Long-Term Oral Anti-thrombotic TReatment In
PAtients with Atrial Fibrillation. (Phase II/III)
Primary Objective
To investigate the patient characteristics influencing the choice of antithrombotic treatment for the prevention of stroke in non-valvular atrial fibrillation (AF) patients. To collect real world data on important outcome events of antithrombotic treatments for the prevention of stroke.
Number of Sites
Period of Study
From:6/14/2013 to:6/14/2020
Number of Patients
IRB Approval Date
TVGH: 2013/07/30; CHGH: 2013/03/04; CGMH-LK: 2013/07/10; MMH: 2013/06/24; CGH: 2013/07/10; NTUH: 2013/06/21; KMUH: 2013/10/08; NCKUH: 2013/08/30; CHMHKS: 2013/08/20; TCVGH: 2013/09/04
Publication Plan / Date